Hong Kong Purevision Limited：Pioneering the Future of Eye Care
Hong Kong Purevision Limited
is an innovative medical technology company rooted in Hong Kong with a global vision. We specialize in introducing and commercializing the world’s most advanced ophthalmic technologies, committed to providing revolutionary solutions for addressing myopia epidemics and eye disease screening across the Asia-Pacific region and global markets.
Our core mission is to serve as the catalyst for pioneering ophthalmic technologies. Through（Exclusive License Agreement）with world-renowned academic institutions, we secure the rights to transform their groundbreaking research into commercially available solutions.
We are currently focused on two core technology areas：
Innovative Solution for Childhood Myopia Management
We introduce to the global market our exclusive combined therapy integrating low-intensity red light therapy with low-dose atropine. Clinically validated, this innovative approach significantly slows the progression of childhood myopia, delivering a safer and more effective solution to the growing worldwide myopia epidemic.
AI Ophthalmology Screening Platform
We develop and promote an artificial intelligence (AI)-based fundus image analysis system. This platform enables rapid, precise, and automated analysis of retinal images, assisting physicians in the early diagnosis of a variety of blinding eye diseases — including diabetic retinopathy, glaucoma, and macular degeneration — to facilitate early screening and treatment.
We are more than a distributor; we are a value-realizing partner for innovative technologies. Our specialized team oversees the critical last mile of product commercialization: from regulatory certification and production quality control to market education and channel development, ensuring that these cutting-edge technologies from top-tier research labs are translated into safe and effective clinical applications.
Starting from Hong Kong, a global metropolitan hub and ideal testing ground, we are actively building successful business models and reference cases. Our strategic roadmap is to progressively introduce these game-changing technologies to the Greater China region, Southeast Asia, and broader Asia-Pacific markets, ultimately bringing transformative care to doctors and patients worldwide.
Hong Kong Purevision Limited looks forward to collaborating with the medical community, partners, and investors to jointly advance ophthalmic care and safeguard clear vision for every patient.